Probably not in the US. But the workaround is already in the article: do it in another more-favorable jurisdiction. Medical tourism for price reasons is alread

Probably not in the US. But the workaround is already in the article: do it in another more-favorable jurisdiction. Medical tourism for price reasons is already a big thing. People are also traveling to Mexico or South Korea for stem-cell treatments unavailable in the US. Startups might also find US jurisdictions that want to carve out more experimental freedom than the FDA's defaults, as with stem cells in Texas: http://www.bloomberg.com/bw/articles/2013-01-03/stem-cell-showdown-celltex-vs-dot-the-fda http://www.bloomberg.com/bw/articles/2013-01-03/stem-cell-sh...